Skip to main content
Heart logoLink to Heart
. 2001 Oct;86(4):456–458. doi: 10.1136/heart.86.4.456

Dilated cardiomyopathy and Chlamydia pneumoniae infection

H SONG, H TASAKI, A YASHIRO, K YAMASHITA, T TOYOKAWA, Y NAGAI, H TAKATSU, H TANIGUCHI, Y NAKASHIMA
PMCID: PMC1729938  PMID: 11559690

Full Text

The Full Text of this article is available as a PDF (137.2 KB).

Figure 1  .

Figure 1  

(A) Values and (B) prevalence of Chlamydia pneumoniae IgG and IgA antibodies in dilated cardiomyopathy patients (n = 26) (black bars) and controls (n=28) (white bars). NS, not significant.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arrighi J. A., Soufer R. Left ventricular diastolic function: physiology, methods of assessment, and clinical significance. J Nucl Cardiol. 1995 Nov-Dec;2(6):525–543. doi: 10.1016/s1071-3581(05)80045-5. [DOI] [PubMed] [Google Scholar]
  2. Bachmaier K., Neu N., Yeung R. S., Mak T. W., Liu P., Penninger J. M. Generation of humanized mice susceptible to peptide-induced inflammatory heart disease. Circulation. 1999 Apr 13;99(14):1885–1891. doi: 10.1161/01.cir.99.14.1885. [DOI] [PubMed] [Google Scholar]
  3. Bachmaier K., Neu N., de la Maza L. M., Pal S., Hessel A., Penninger J. M. Chlamydia infections and heart disease linked through antigenic mimicry. Science. 1999 Feb 26;283(5406):1335–1339. doi: 10.1126/science.283.5406.1335. [DOI] [PubMed] [Google Scholar]
  4. Ikonomidis I., Andreotti F., Economou E., Stefanadis C., Toutouzas P., Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 1999 Aug 24;100(8):793–798. doi: 10.1161/01.cir.100.8.793. [DOI] [PubMed] [Google Scholar]
  5. Iskandrian A. S., Heo J., Segal B. L., Askenase A. Left ventricular diastolic function: evaluation by radionuclide angiography. Am Heart J. 1988 Apr;115(4):924–929. doi: 10.1016/0002-8703(88)90905-2. [DOI] [PubMed] [Google Scholar]
  6. Laurila A. L., Anttila T., Lärä E., Bloigu A., Virtamo J., Albanes D., Leinonen M., Saikku P. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer. 1997 Feb 20;74(1):31–34. doi: 10.1002/(sici)1097-0215(19970220)74:1<31::aid-ijc6>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  7. Mancini G. B., Slutsky R. A., Norris S. L., Bhargava V., Ashburn W. L., Higgins C. B. Radionuclide analysis of peak filling rate, filling fraction, and time to peak filling rate. Response to supine bicycle exercise in normal subjects and patients with coronary disease. Am J Cardiol. 1983 Jan 1;51(1):43–51. doi: 10.1016/s0002-9149(83)80009-5. [DOI] [PubMed] [Google Scholar]
  8. Mozes G., Mohacsi T., Gloviczki P., Menawat S., Kullo I., Spector D., Taylor J., Crotty T. B., O'Brien T. Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo. Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1157–1163. doi: 10.1161/01.atv.18.7.1157. [DOI] [PubMed] [Google Scholar]
  9. Perrone-Filardi P., Bacharach S. L., Dilsizian V., Bonow R. O. Impaired left ventricular filling and regional diastolic asynchrony at rest in coronary artery disease and relation to exercise-induced myocardial ischemia. Am J Cardiol. 1991 Feb 15;67(5):356–360. doi: 10.1016/0002-9149(91)90041-i. [DOI] [PubMed] [Google Scholar]
  10. Qiao J. H., Tripathi J., Mishra N. K., Cai Y., Tripathi S., Wang X. P., Imes S., Fishbein M. C., Clinton S. K., Libby P. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol. 1997 May;150(5):1687–1699. [PMC free article] [PubMed] [Google Scholar]
  11. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996 Mar 1;93(5):841–842. doi: 10.1161/01.cir.93.5.841. [DOI] [PubMed] [Google Scholar]
  12. Tashiro H., Shimokawa H., Yamamoto K., Momohara M., Tada H., Takeshita A. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Artery Dis. 1997 Mar-Apr;8(3-4):143–147. doi: 10.1097/00019501-199703000-00004. [DOI] [PubMed] [Google Scholar]
  13. Verkooyen R. P., Van Lent N. A., Mousavi Joulandan S. A., Snijder R. J., van den Bosch J. M., Van Helden H. P., Verbrugh H. A. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA. J Med Microbiol. 1997 Nov;46(11):959–964. doi: 10.1099/00222615-46-11-959. [DOI] [PubMed] [Google Scholar]
  14. Yusuf S., Pepine C. J., Garces C., Pouleur H., Salem D., Kostis J., Benedict C., Rousseau M., Bourassa M., Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992 Nov 14;340(8829):1173–1178. doi: 10.1016/0140-6736(92)92889-n. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES